咖啡酸衍生物作为弹性酶抑制剂:机制性见解和治疗潜力
Lihao Lin1, Jinfeng Fu2, Hongliu Yao2
1Department of Neurosurgery, First Hospital of Jilin University, Changchun 130021, China.
International journal of biological macromolecules
|April 13, 2025
概括
咖啡酸,酸和福西化物A抑制弹性酶,这是炎症性疾病中的关键酶. 福西胺A显示出最强的抑制作用,为新药开发提供了潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 炎症涉及弹性酶的过度生产,降解结构蛋白质,并导致COPD和类风湿性关节炎等疾病.
- 开发有效的弹性酶抑制剂对于管理炎症状况至关重要.
研究的目的:
- 为了研究咖啡酸及其衍生物,原酸和福西化物A.的弹性酶抑制潜力.
- 阐明这些化合物抑制弹性酶的基础分子机制.
主要方法:
- 酶动力学测试以确定抑制类型和有效性.
- 多种光谱技术 (光,紫外线) 用于研究酶-化合物相互作用.
- 分子对接模拟用于预测结合模式和相互作用.
主要成果:
- 这三种化合物都具有竞争性抑制弹性酶的作用.
- 福西提亚胺A显示出最高的抑制功效.
- 光谱数据表明,复合物结合时弹性酶的二次结构变化.
- 热力学分析显示,不同化合物的相互作用力 (静电与结合) 是不同的.
- 分子对接确定了对抑制有贡献的关键功能组 (ortho-phenolic hydroxyl, polyhydroxy).
结论:
- 咖啡酸衍生物具有显著的弹性酶抑制活性.
- 福西化物A是一种强大的弹性酶抑制剂,具有潜在的治疗应用.
- 了解结构-活性关系指导着针对炎症性疾病的新型弹性酶抑制剂的开发.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
394
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
394
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Enzyme Inhibition
77.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.5K
Adrenergic Agonists: Indirect-Acting Agents
1.4K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.4K
Introduction to Enzymes
16.9K
The use of enzymes by humans dates to 7000 BCE. Humans first used enzymes to ferment sugars and produce alcohol without knowing that this was an enzyme-catalyzed reaction. Wilhelm Kuhne coined the term 'enzyme' in 1877 from the Greek words ‘en’ meaning ‘in’ or ‘within’ and ‘zyme’ meaning ‘yeast.’
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
Most enzymes are proteins that speed up biochemical reactions without being consumed. Enzymes contain one or more active sites that...
16.9K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K


